These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6627468)

  • 41. Pathologic evaluation of thymic hyperplasia in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Grody WW; Jobst S; Keesey J; Herrmann C; Naeim F
    Arch Pathol Lab Med; 1986 Sep; 110(9):843-6. PubMed ID: 3755894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus.
    Meyer M; Höls AK; Liersch B; Leistner R; Gellert K; Schalke B; Marx A; Niedobitek G
    Ann Neurol; 2011 Sep; 70(3):515-8. PubMed ID: 21905083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T- and B-cells in thymus and blood in myasthenia gravis.
    Bhuyan UN; Nath I; Singh N; Prusty SN
    Indian J Med Res; 1977 Jun; 65(6):871-6. PubMed ID: 304842
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in the thymus in patients with myasthenia and their importance for the choice of surgical approach].
    Kuzin MI; Kabanov NIa
    Grudn Khir; 1966; 8(3):92-5. PubMed ID: 5981532
    [No Abstract]   [Full Text] [Related]  

  • 45. AMP-deaminase from thymus of patients with myasthenia gravis.
    Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Familial myasthenia gravis: report of 2 brothers].
    de Freitas MR; Gomes SE; Cincinatus D; Garcia JM; Nevares MT; Hahn MD
    Arq Neuropsiquiatr; 1985 Mar; 43(1):80-5. PubMed ID: 4015442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunomorphologic and ultrastructural features of the thymus in myasthenia].
    Odinokova VA; Gurevich LE; Sanovich EIa; Agafonov BV; Ol'shanskiĭ AIa
    Sov Med; 1990; (11):17-21. PubMed ID: 2075514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thymus in myasthenia gravis with special reference to the significance of Hassall's corpuscles.
    Kouvalainen K; Wallgren GR
    Ann Med Exp Biol Fenn; 1967; 45(1):112-6. PubMed ID: 6062799
    [No Abstract]   [Full Text] [Related]  

  • 51. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
    Ambrogi V; Mineo TC
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus in myasthenia gravis thymus: a matter of debate.
    Serafini B; Cavalcante P; Bernasconi P; Aloisi F; Mantegazza R
    Ann Neurol; 2011 Sep; 70(3):519. PubMed ID: 21905084
    [No Abstract]   [Full Text] [Related]  

  • 53. Morphometric analysis of germinal centers in nonthymomatous patients with myasthenia gravis.
    Moran CA; Suster S; Gil J; Jagirdar J
    Arch Pathol Lab Med; 1990 Jul; 114(7):689-91. PubMed ID: 2363627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathological anatomy of myasthenia].
    Gornak KA; Kop'eva TN
    Arkh Patol; 1965; 27(10):12-21. PubMed ID: 5871287
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prognostic importance of thymic germinating centers in cases of myasthenia gravis pseudoparalytica].
    Schönfelder M; Baumann I
    Psychiatr Neurol Med Psychol (Leipz); 1974 Sep; 26(9):556-64. PubMed ID: 4449919
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: B lymphocytes in the thymus of patients with myasthenia gravis.
    Staber FG; Fink U; Sack W
    N Engl J Med; 1975 May; 292(19):1032-3. PubMed ID: 1078872
    [No Abstract]   [Full Text] [Related]  

  • 57. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
    Hill ME; Shiono H; Newsom-Davis J; Willcox N
    J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The thymus in myasthenia gravis.
    Wekerle H; Müller-Hermelink HK
    Curr Top Pathol; 1986; 75():179-206. PubMed ID: 3514159
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thymic abnormalities in patients with myasthenia gravis].
    Utsugisawa K; Nagane Y
    Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.